Search Results 131-140 of 11512 for Cirrhosis

  1. A Study To Test Whether BI 3802876 Is Tolerated In People With Compensated Liver Cirrhosis Due To Metabolic Dysfunction- Associated Steatohepatitis (MASH) - Mayo Clinic

    This study is open to adults with a type of confirmed liver condition called compensated cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) ...

  2. Nonalcoholic fatty liver disease - Diagnosis and treatment - Mayo Clinic

    Magnetic resonance imaging (MRI) or computerized tomography (CT) scanning. These tests are better at finding excess liver fat and cirrhosis. Transient ...

  3. Symptoms and causes - Mayo Clinic

    MASH also causes fat deposits in the liver, which causes liver damage. MASH may get worse and may lead to serious liver scarring, called cirrhosis, or even ...

  4. Fatty liver disease (MASLD) - Diagnosis and treatment - Mayo Clinic

    Magnetic resonance imaging (MRI) or computerized tomography (CT) scanning. These tests are better at finding excess liver fat and cirrhosis. Transient ...

  5. Treatment of Muscle Cramps in Patients with Liver Cirrhosis - Mayo Clinic

    This is a pilot study to see if hydroxychloroquine (HCQ) if safe and effective to use with patients having cramps due to their cirrhotic liver disease.

  6. Genotype Optimal Regimens 1 GLE/PIB 8 wks a-TE with PEG/RBV, no cirrhosis 8 wks b-Cirrhosis and TE with non-NS5A DAA 12 wks c-ES

    b-Decomp cirrhosis, or NS3A/PI+PEG-IFN/RBV TE with cirrhosis, or post-LT, add. RBV* c-SOF/RBV TE, add RBV 12 wks, if cirrhosis, add RBV 24 wks. SOF/VEL 12 wks.

  7. Portal hypertension - Diagnosis and treatment - Mayo Clinic

    If you have known risk factors for portal hypertension, such as cirrhosis, as well as symptoms, that may be all that's needed to make the diagnosis.

  8. Simtuzumab (GS-6624) In The Treatment Of Cirrhosis Due To NASH - Mayo Clinic

    This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH).

  9. Development of a Novel Vocal Biomarker in the Diagnosis and Management of Hepatic Encephalopathy - Mayo Clinic

    Hepatic encephalopathy (HE) is a serious complication of cirrhotic stage liver disease. It is reported that 30-70% of all patients with cirrhosis have HE.

  10. Portal hypertension - Care at Mayo Clinic

    Accurate diagnosis and staging of cirrhosis, the cause of most portal ... cirrhosis. This advanced technology allows liver disease to be detected and ...